Gemzar and alanine aminotransferase increased Patient Reports February 13, 2012

Gemzar Side Effects Report #5391080-8
Gemzar side effect was reported by a Physician from SWITZERLAND on July 14, 2007. Female patient, 67 years of age, weighting 141.1 lb, was diagnosed with peritoneal carcinoma, prophylaxis of nausea and vomiting, cardiac disorder, renal failure, sleep disorder

. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with KYTRIL, DECADRON #. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5129137-9
Gemzar side effect was reported by a Pharmacist from JAPAN on Sept 21, 2006. Male patient, 70 years of age, weighting 132.3 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, jaundice cholestatic, white blood cell count decreased. Gemzar dosage: 1000 MG/M^2, OTHER, INTRAVENOUS. During the same period patient was treated with OXYCONTIN, NOVAMIN, MAGNESIUM OXIDE. Patient recovered.

Gemzar Side Effects Report #5130076-8
Gemzar side effect was reported by a Pharmacist from JAPAN on Sept 28, 2006. Male patient, 70 years of age, weighting 132.3 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biliary dilatation, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic enzyme increased, jaundice cholestatic. Gemzar dosage: 1000 MG/M^2, OTHER, INTRAVENOUS. During the same period patient was treated with OXYCONTIN, NOVAMIN, MAGNESIUM OXIDE. Patient recovered.

Gemzar Side Effects Report #5800212-6
Gemzar side effect was reported by a Physician from JAPAN on June 23, 2008. Female patient, weighting 108.0 lb, was diagnosed with pancreatic carcinoma stage iv, constipation

, prophylaxis, pancreatic enzymes, hyperchlorhydria, schizophrenia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cerebral infarction, fall

, hepatic function abnormal, malignant neoplasm progression, sepsis

. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with BIO THREE, FOIPAN, PANCREATIN TRIPLE STRENGTH CAP, GASMOTIN, TAKEPRON, ALOSENN, SERENACE, AKINETON. Patient died on 05/28/2008.

Gemzar Side Effects Report #5084495-9
Gemzar side effect was reported by a Physician from JAPAN on July 31, 2006. Male patient, 85 years of age, was diagnosed with pancreatic carcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacteria urine identified, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, false positive laboratory result, fungus urine test positive, gamma-glutamyltransferase increased. Gemzar dosage: 1500 MG, OTHER, INTRAVENOUS. Patient died on 02/16/2004.

Gemzar Side Effects Report #5130172-5
Gemzar side effect was reported by a Physician from UNITED STATES on Sept 26, 2006. Female patient, 67 years of age, weighting 181.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bacterial sepsis, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood potassium increased, blood urea increased. Gemzar dosage: 1400 MG, INTRAVENOUS; SEE IMAGE. During the same period patient was treated with XELODA, LASIX, METFORMIN, SPIRONOLACTONE, GLYBURIDE, HORMONES AND RELATED AGENTS, NEURONTIN. Patient was hospitalized. Patient died on 08/30/2006.

Gemzar Side Effects Report #4832745-3
Gemzar side effect was reported by a Physician from UNITED STATES on Nov 08, 2005. Male patient, 67 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, confusional state, diarrhoea, hyponatraemia. Gemzar dosage: 1000 MG. During the same period patient was treated with COUMADIN, LOVENOX, ZOLOFT, DURAGESIC, MORPHINE, LOMOTIL. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #4843603-2
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2005. Male patient, 67 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cellulitis

, chest pain

, chills, confusional state, constipation

. Gemzar dosage: 1000 MG. During the same period patient was treated with COUMADIN, LOVENOX, ZOLOFT, DURAGESIC, MORPHINE, LOMOTIL, ZOFRAN, COLACE. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #4860890-5
Gemzar side effect was reported by a Physician from JAPAN on Nov 30, 2005. Male patient, 78 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood sodium decreased, bone marrow failure, ileus paralytic. Gemzar dosage: 800 MG/M2, OTHER, INTRAVENOUS. Patient died on 01/01/2004.

Gemzar Side Effects Report #4799272-3
Gemzar side effect was reported by a Pharmacist from IRELAND on Jan 20, 2005. Male patient, 70 years of age, weighting 165.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, bone marrow toxicity, gamma-glutamyltransferase increased. Gemzar dosage: 1800 MG/2 OTHER IV. During the same period patient was treated with MORPHINE SULPHATE, MOVICOL, CELEBREX, LANSOPRAZOLE, CALOGEN, MEGACE. Patient recovered.

Gemzar Side Effects Report #5361924-4
Gemzar side effect was reported by a Physician from SWITZERLAND on June 05, 2007. Female patient, 67 years of age, weighting 141.1 lb, was diagnosed with pancreatic carcinoma, prophylaxis of nausea and vomiting, cardiac disorder, renal failure, sleep disorder

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase abnormal, serum ferritin increased. Gemzar dosage: 1000 MG/M2, UNK. During the same period patient was treated with NAVOBAN, ASPIRIN, BELOC ZOK, ATORVASTATIN CALCIUM, CALCIUM ACETATE, VALVERDE, PANTOZOL, ZOLPIDEM. Patient recovered.

Gemzar Side Effects Report #5016878-7
Gemzar side effect was reported by a Physician from JAPAN on May 16, 2006. Female patient, 67 years of age, weighting 83.78 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, cerebral infarction, coma hepatic, diabetes mellitus inadequate control. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4599885-8
Gemzar side effect was reported by a Physician from on Feb 14, 2005. Male patient, 62 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, c-reactive protein increased, granulocyte count increased, neoplasm progression, peritonitis bacterial. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with DEXAMETHASONE, KEVATRIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4625890-9
Gemzar side effect was reported by a Physician from on Mar 14, 2005. Male patient, 62 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, c-reactive protein increased, malignant neoplasm progression, pancreatic carcinoma, peritonitis bacterial, subileus. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with DEXAMETHASONE, KEVATRIL. Patient was hospitalized. Patient died on 02/01/2005.

Gemzar Side Effects Report #4662773-2
Gemzar side effect was reported by a Health Professional from on Apr 22, 2005. Male patient, 61 years of age, weighting 123.5 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, constipation

, eating disorder

. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with MORPHINE ELIXIR, HUMULIN R, ROHYPNOL. Patient recovered.

Gemzar Side Effects Report #5675309-4
Gemzar side effect was reported by a Physician from UNITED STATES on Oct 09, 2007. Female patient, 55 years of age, weighting 108.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, erythema, gamma-glutamyltransferase increased, limb discomfort, neuropathy peripheral, oedema peripheral. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, OXYCODONE, OXYCONTIN, MORPHINE SULPHATE, REGLAN, MEGACE, KYTRIL, DULCOLAX. Patient recovered.

Gemzar Side Effects Report #6114682-X
Gemzar side effect was reported by a Physician from UNITED STATES on June 02, 2008. Female patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, dry eye. Gemzar dosage: unknown. During the same period patient was treated with CREON. Patient recovered.

Gemzar Side Effects Report #5113556-0
Gemzar side effect was reported by a Physician from JAPAN on Aug 31, 2006. Female patient, 53 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain

, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, chills, gamma-glutamyltransferase increased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOTERE, GLYBURIDE, VOLTAREN. Patient was hospitalized. Patient died on 11/17/2003.

Gemzar Side Effects Report #4990738-X
Gemzar side effect was reported by a Health Professional from UNITED STATES on Aug 11, 2005. Female patient, 48 years of age, weighting 129.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, malignant neoplasm progression. Gemzar dosage: 1254 MG/M2, INTRAVENOUS. During the same period patient was treated with OXYCONTIN, AMBIEN. Patient recovered.

Gemzar Side Effects Report #5337619-X
Gemzar side effect was reported by a Physician from UNITED STATES on May 19, 2006. Female patient, 44 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, hepatotoxicity. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA. Patient recovered.

Gemzar Side Effects Report #5675284-2
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 07, 2008. Male patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, disease progression. Gemzar dosage: 1000 MG/M2. Patient recovered.

Gemzar Side Effects Report #4642409-7
Gemzar side effect was reported by a Health Professional from on Apr 21, 2005. Female patient, weighting 99.21 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, diarrhoea. Gemzar dosage: 525MG/M2 QWEEKX3 INTRAVENOU. Patient recovered.

Gemzar Side Effects Report #4648811-1
Gemzar side effect was reported by a Physician from on Apr 11, 2005. Female patient, 57 years of age, was diagnosed with ovarian epithelial cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine increased, blood lactate dehydrogenase increased, blood pressure increased, haemolytic uraemic syndrome, stomatitis. Gemzar dosage: 1500 MG/M2 OTHER. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient died on 11/01/2003.

Gemzar Side Effects Report #4887565-0
Gemzar side effect was reported by a Physician from JAPAN on Jan 05, 2006. Male patient, 54 years of age, weighting 138.5 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, lung infiltration, pneumonia

, pneumonitis. Gemzar dosage: 1700 MG, OTHER, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, CHLORIDE, DROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4900766-8
Gemzar side effect was reported by a Physician from JAPAN on Jan 13, 2006. Male patient, 54 years of age, weighting 138.5 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, bronchoalveolar lavage abnormal, lung neoplasm malignant, malignant neoplasm progression, pneumonitis. Gemzar dosage: 1700 MG, OTHER INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, CHLORIDE, FAMOTIDINE, ONDANSETRON HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5337812-6
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 08, 2006. Female patient, 72 years of age, weighting 162.9 lb, was diagnosed with non-small cell lung cancer stage iiib and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, contusion, gingival bleeding, haematocrit decreased, haematuria. Gemzar dosage: 1100 MG/M2, OTHER, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5078405-8
Gemzar side effect was reported by a Physician from BELGIUM on July 25, 2006. Male patient, 74 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood amylase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, lipase increased, renal failure. Gemzar dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with PLATINOL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5337811-4
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood urea increased, dyspnoea, platelet count increased, pulmonary toxicity, white blood cell count increased. Gemzar dosage: unknown. During the same period patient was treated with ASA, VITAMINS, ASCORBIC ACID, COMPAZINE, SENOKOT, PREVACID, POTASSIUM CHLORIDE, MAGNESIUM. Patient recovered.

Gemzar Side Effects Report #4992655-8
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood urea increased, dyspnoea, dyspnoea exacerbated, platelet count increased, pulmonary toxicity, white blood cell count increased. Gemzar dosage: unknown. During the same period patient was treated with ASA, VITAMINS, ASCORBIC ACID, COMPAZINE, SENOKOT, PREVACID, POTASSIUM CHLORIDE, MAGNESIUM. Patient recovered.

Gemzar Side Effects Report #4641980-9
Gemzar side effect was reported by a Pharmacist from on Mar 31, 2005. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, asthenia, atherosclerosis, bilirubin conjugated increased, blood albumin increased, blood alkaline phosphatase increased. Gemzar dosage: 900 MG. During the same period patient was treated with CARBOPLATIN, AMBIEN, QUININE SULPHATE, COMPRAZINE, ALBUTEROL, PAIN MEDS, ATIVAN, ZOFRAN. Patient was hospitalized. Patient died on 05/19/2004.

Gemzar Side Effects Report #5833353-8
Gemzar side effect was reported by a Physician from UNITED KINGDOM on July 23, 2008. Female patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abnormal clotting factor, alanine aminotransferase increased, gamma-glutamyltransferase increased, liver function test abnormal, lower respiratory tract infection, nausea

. Gemzar dosage: unknown. During the same period patient was treated with ANTIEMETICS AND ANTINAUSEANTS, ANALGESICS. Patient recovered.

Gemzar Side Effects Report #5874267-7
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Aug 26, 2008. Female patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abnormal clotting factor, alanine aminotransferase increased, gamma-glutamyltransferase increased, liver function test abnormal, lower respiratory tract infection, nausea

, sepsis

. Gemzar dosage: unknown. During the same period patient was treated with ANTIEMETICS AND ANTINAUSEANTS, ANALGESICS. Patient recovered.

Gemzar Side Effects Report #5020686-0
Gemzar side effect was reported by a Physician from UNITED STATES on May 11, 2006. Male patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain

, abdominal tenderness, alanine aminotransferase increased, anaemia, ascites, back pain

, blood albumin decreased, blood alkaline phosphatase increased. Gemzar dosage: 500 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with VALTREX, BACTRIM, SEROQUEL, DIFLUCAN, ALLOPURINOL, RITUXAN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #6016162-9
Gemzar side effect was reported by a Physician from UNITED STATES on Dec 15, 2008. Female patient, weighting 214.0 lb, was diagnosed with metastatic uterine cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, fatigue, headache

, hip fracture, nausea

, pancytopenia. Gemzar dosage: 1000 MG/M2, DAY 1 AND 8. During the same period patient was treated with CARBOPLATIN, FENTANYL, NEULASTA. Patient recovered.

Gemzar Side Effects Report #4883730-7
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 03, 2006. Male patient, 65 years of age, was diagnosed with metastases to liver and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, duodenal ulcer, gastric ulcer, gastrointestinal haemorrhage, international normalised ratio increased. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with WARFARIN. Patient recovered.

Gemzar Side Effects Report #4639984-5
Gemzar side effect was reported by a Physician from on Mar 30, 2005. Female patient, 79 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, c-reactive protein increased, febrile neutropenia, gastrointestinal haemorrhage, haemoglobin decreased, thrombocytopenia, white blood cell agglutination present. Gemzar dosage: 1350 MG. During the same period patient was treated with CARBOPLATIN, THYROXINE, ZYRTEC, DETRUSITOL, ALBYL, ZOCOR. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4642054-3
Gemzar side effect was reported by a Physician from on Mar 30, 2005. Female patient, 79 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, c-reactive protein increased, febrile neutropenia, gastric ulcer, gastrointestinal haemorrhage, haemoglobin decreased, thrombocytopenia, white blood cell agglutination present. Gemzar dosage: 1350 MG OTHER. During the same period patient was treated with CARBOPLATIN, THYROXINE, ZYRTEC, DETRUSITOL, ALBYL, ZOCOR. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5129138-0
Gemzar side effect was reported by a Pharmacist from JAPAN on Sept 25, 2006. Male patient, 77 years of age, weighting 125.7 lb, was diagnosed with lung adenocarcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bedridden, blood creatine increased, blood urea increased, cardiac failure, cardio-respiratory arrest, hyperkalaemia, liver disorder. Gemzar dosage: 1600 MG, OTHER, INTRAVENOUS. During the same period patient was treated with PARAPLATIN, MAGNESIUM OXIDE, LOXONIN, FAMOTIDINE, BROCIN, METHYLPREDNISOLONE, ROCEPHIN, SOLDEM. Patient died on 04/06/2006.

Gemzar Side Effects Report #4990825-6
Gemzar side effect was reported by a Pharmacist from JAPAN on Apr 19, 2006. Male patient, 77 years of age, weighting 125.7 lb, was diagnosed with lung adenocarcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood potassium increased, blood urea increased, cardio-respiratory arrest, hyperkalaemia, liver disorder, malaise. Gemzar dosage: 1600 MG, OTHER, INTRAVENOUS. During the same period patient was treated with PARAPLATIN, MAGNESIUM OXIDE, LOXONIN, GASTER D, BROCIN, METHYLPREDNISOLONE SUCCINATE, ROCEPHIN, SOLDEM. Patient died on 04/06/2006.

Gemzar Side Effects Report #4999896-4
Gemzar side effect was reported by a Pharmacist from JAPAN on Apr 24, 2006. Male patient, 77 years of age, weighting 125.7 lb, was diagnosed with lung adenocarcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bedridden, blood creatinine increased, blood urea increased, cardio-respiratory arrest, cough, hyperkalaemia. Gemzar dosage: 1600 MG, OTHER; INTRAVENOUS. During the same period patient was treated with PARAPLATIN, MAGNEISIUM OXIDE, LOXONIN, GASTER D, BROCIN, METHYLPREDNISOLONE, ROCEPHIN, SOLDEM. Patient died on 04/06/2006.

Gemzar Side Effects Report #4855685-2
Gemzar side effect was reported by a Physician from JAPAN on Dec 02, 2005. Male patient, 84 years of age, was diagnosed with gallbladder cancer

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dysstasia, pyrexia, rhabdomyolysis. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4992725-4
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2005. Female patient, 49 years of age, weighting 192.2 lb, was diagnosed with gallbladder cancer

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain

, activated partial thromboplastin time prolonged, alanine aminotransferase increased, alopecia, anxiety

, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with COUMADIN, ATENOLOL, HYDROCHLOROTHIAZIDE, GRAPE SEED, BIOTIN, FISH OIL, XANAX. Patient recovered.

Gemzar Side Effects Report #4655324-X
Gemzar side effect was reported by a Health Professional from on Apr 14, 2005. Female patient, 57 years of age, weighting 178.6 lb, was diagnosed with breast cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alopecia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, epistaxis, rash pruritic, rash pustular, recall phenomenon. Gemzar dosage: unknown. During the same period patient was treated with HERCEPTIN. Patient recovered.

Gemzar Side Effects Report #4709563-X
Gemzar side effect was reported by a Health Professional from UNITED STATES on June 17, 2005. Female patient, 57 years of age, weighting 176.4 lb, was diagnosed with breast cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alopecia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, epistaxis, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression. Gemzar dosage: unknown. During the same period patient was treated with HERCEPTIN. Patient recovered.

Gemzar Side Effects Report #4641992-5
Gemzar side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 57 years of age, weighting 178.6 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alopecia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, epistaxis, rash pruritic, rash pustular, recall phenomenon. Gemzar dosage: unknown. During the same period patient was treated with HERCEPTION. Patient recovered.

Gemzar Side Effects Report #5129240-3
Gemzar side effect was reported by a Physician from ITALY on Sept 21, 2006. Female patient, 39 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, palmar-plantar erythrodysaesthesia syndrome. Gemzar dosage: 1250 MG, OTHER, INTRAVENOUS. During the same period patient was treated with TAXOTERE, KYTRIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5678648-6
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 11, 2008. Female patient, weighting 124.0 lb, was diagnosed with breast cancer metastatic, hypertension, gastrooesophageal reflux disease, nausea

, decreased appetite and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, confusional state, coordination abnormal, dyspnoea, hepatic enzyme abnormal, leukocytosis. Gemzar dosage: unknown. During the same period patient was treated with LISINOPRIL, MORPHINE, ACIPHEX, COMPAZINE, MARINOL, KYTRIL, LEVAQUIN, LORAZEPAM. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5846579-4
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2008. Female patient, weighting 145.0 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dehydration, fatigue. Gemzar dosage: 2200 MG, OTHER. During the same period patient was treated with XANAX, AMITRIPTYLINE, ACTONEL, METOPROLOL, COMPAZINE, DARVOCET, ZYRTEC, HERBAL PREPARATION. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5889497-8
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 08, 2008. Female patient, weighting 145.0 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dehydration, fatigue. Gemzar dosage: 2200 MG, OTHER. During the same period patient was treated with XANAX, AMITRIPTYLINE, ACTONEL, METOPROLOL TARTRATE, COMPAZINE, DARVOCET, ZYRTEC, HERBAL PREPARATION. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5675392-6
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 20, 2007. Female patient was diagnosed with breast cancer

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain

, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. Gemzar dosage: unknown. During the same period patient was treated with AVASTIN. Patient recovered.

Gemzar Side Effects Report #5716023-6
Gemzar side effect was reported by a Physician from UNITED STATES on Apr 14, 2008. Female patient was diagnosed with breast cancer

, asthma

, diabetes mellitus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cardiac cirrhosis, cardiomyopathy

, haemoglobin abnormal, obstruction gastric, vomiting. Gemzar dosage: 1000 MG/M2, UNK. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4802989-5
Gemzar side effect was reported by a Physician from JAPAN on Sept 22, 2005. Male patient, 63 years of age, weighting 143.3 lb, was diagnosed with bladder cancer

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, arthralgia, aspartate aminotransferase increased, back pain

, blood albumin decreased, blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with AMLODIPINE BESYLATE, METHYLCOBAL, MUCOSTA, GLIMICRON, TOLNAFTATE, HUMULIN R. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5673242-5
Gemzar side effect was reported by a Physician from JAPAN on Mar 12, 2008. Male patient, 62 years of age, was diagnosed with bile duct cancer non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cholangitis, hepatic function abnormal, malignant neoplasm progression. Gemzar dosage: 1000 MG, OTHER. Patient died.

Gemzar Side Effects Report #4608773-X
Gemzar side effect was reported by a Physician from on Mar 01, 2005. Female patient, 62 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, condition aggravated, gamma-glutamyltransferase increased, haemoglobin decreased, haemolysis. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with METRONIDAZOLE, CIPROFLOXACIN, DUROGESIC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4613257-9
Gemzar side effect was reported by a Physician from on Mar 01, 2005. Female patient, 62 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, condition aggravated, gamma-glutamyltransferase increased, haemolysis, thrombocytopenia. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with METRONIDAZOLE, CIPROFLOXACIN, DUROGESIC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4666345-5
Gemzar side effect was reported by a Pharmacist from on May 02, 2005. Male patient, 50 years of age, weighting 134.5 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alcohol withdrawal syndrome, aspartate aminotransferase increased, atelectasis, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with METOPROLOL, FOLIC ACID, ASPIRIN, TRAZODONE, THIAMINE MONONITRATE, RISPERDAL, DIGOXIN, PHENYTOIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5966088-1
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 12, 2008. Female patient, 70 years of age, was diagnosed with adenocarcinoma pancreas, atrial fibrillation

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, malignant neoplasm progression. Gemzar dosage: unknown. During the same period patient was treated with TAXOTERE, CAPECITABINE, WARFARIN. Patient recovered.

Gemzar Side Effects Report #5950101-1
Gemzar side effect was reported by a Physician from UNITED STATES on Nov 04, 2008. Female patient, weighting 214.0 lb, was treated with Gemzar. After drug was administered, patient experienced the following side effects: activities of daily living impaired, alanine aminotransferase increased, anorexia, arthralgia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, endometrial cancer metastatic, erythema, fatigue. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, FENTANYL. Patient recovered.

Gemzar and alanine aminotransferase increased

SideEffects101.com

Gemzar and alanine aminotransferase increased Patient Reports February 13, 2012

side effects of Gemzar